July 15, 2015

In Vivo

Mining The Microbiome: Are Gut Microbes The Next Big Source Of Drugs?

Executive Summary

There is growing interest in the gut microbiome as a source of new therapies across a wide range of diseases. Although it is still an emerging field, pharmaceutical firms and other investors are engaging, with more expected to follow.

* Second Genome is featured.

More at: https://www.pharmamedtechbi.com/publications/in-vivo/33/7/mining-the-microbiome-are-gut-microbes-the-next-big-source-of-drugs